Poseida Therapeutics, Inc. announced appointments to new roles on its executive leadership team. Effective immediately, Johanna Mylet, C.P.A., will serve as Chief Financial Officer; Devon Shedlock, Ph.D., will become Chief Scientific Officer, Cell Therapies; Kristin Martin will assume the role of Chief People and Administration Officer; and Lisa Portale will become Senior Vice President, Regulatory Affairs.